TIANJIN TIANYAO PHARMACEUTICALS CO., LTD.

Andere talen Tianjin Tianyao Pharmaceuticals Co., Ltd.

Aandelen

600488

CNE000001840

slotkoers Shanghai S.E. Andere beurzen 00:00:00 08-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
4,35 ^CNY	+3,82%		+6,36%	-11,22%

07:11	Jinyao Pharmaceutical krijgt toestemming om betamethasondipropionaat in Europa op de markt te brengen	MT
26/04	Tianjin Tianyao Pharmaceuticals Co, Ltd. rapporteert winstresultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Jinyao Pharmaceutical Gets Nod to Market Betamethasone Dipropionate in Europe	07:11
Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Jinyao Pharma's Unit Gets Approval to Market Compound Ipratropium Bromide Solution	25/04
Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Jinyao Pharma Unit's Fluconazole Chloride Passes Regulatory Evaluation	08/03
Jinyao Pharma Unit's Metoclopramide Hydrochloride Injection Passes Regulatory Evaluation	29/02
Jinyao Pharma Unit's Clindamycin Phosphate Passes Drug Regulator's Evaluation	11/01
Jinyao Pharmaceutical's Drugs Chosen for China's Centralized Procurement Bid	08/11
Jinyao Pharmaceutical Gets Nod to Market Travoprost	03/11
Tianyao Pharma’s Brain Injury Drug Passes Generic Drug Consistency Test	02/11
Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27-10-23
Jinyao Pharmaceutical Unit's Methylcobalamin Injection Passes Drug Regulator's Evaluation	23-10-23
Jinyao Pharmaceutical Gets Nod to Market Two Raw Drug Materials	12-10-23
Tianjin Tianyao Pharmaceuticals Co., Ltd.(XSSC:600488) added to S&P Global BMI Index	18-09-23
Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29-08-23
Jinyao Pharmaceutical Unit's Tumor Drug Passes Regulatory Evaluation	01-08-23
Jinyao Pharmaceutical Gets Nod for Marketing Application of Raw Drug Material	14-07-23
Tianjin Tianyao Pharma Receives 35 Million Yuan in Government Subsidies	29-05-23
Tianyao Pharma Registers Inhalation Drug	23-05-23
Jinyao Pharmaceutical's Unit Gets Nod to Topical Cream's Registration	10-05-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Tianjin Tianyao Pharmaceuticals Co., Ltd.

Aandelen

600488

CNE000001840

Andere talen

Filters